Patent · US Active

Selective glycosidase inhibitors and uses thereof

US9718854B2 · kind B2 · utility

0Cited by
15References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 20, 2012
Grant dateAug 1, 2017
Priority date
Expiry dateMar 20, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y302/01169
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compounds of formula (I) with substituents as specified in claim 1 for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceuticals compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to over-expression of O-GlcNAcase or accumulation of O-GlcNac.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.